Luis Felipe León Madero

Dr. Luis Felipe León Madero

Coordinación de Genética y Genómica Humana, Instituto Nacional de Perinatología, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2024 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
LMLuis Felipe León Madero
Luis Felipe León Madero
CFCesar Humberto Fregoso‐Ron
Cesar Humberto Fregoso‐Ron
JLJuan Carlos De León‐Carbajal
Juan Carlos De León‐Carbajal
JVJuan Manuel Valdés‐Miranda
Juan Manuel Valdés‐Miranda
Background: Ellis‐van Creveld syndrome (EvCS) is a chondroectodermal dysplasia caused by germline pathogenic variants in ciliary complex subunit 1 and 2 genes (EVC, EVC2) on chromosome 4p16.2. This disease has a broad phenotype, and there are few described phenotype–genotype correlations.Methods: Ethical Compliance: Written informed consent was obtained from the parents. Here, we report a genetically confirmed Mexican patient with EvCS having two inherited pathogenic variants in trans in EVC2: c.[1195C>T];[2161delC].Results: This patient allowed a genotypic–phenotypic comparison with another Mexican subject who presented a more attenuated phenotype; furthermore, our patient also presented cleft palate, a rarely reported feature.Conclusion: Our case shows the importance of comparing functional hemizygosity between patient's phenotypes when they share a variant, and our case also supports the association of alterations in the palate as part of the EvCS phenotype.

7 December 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
LMLuis Felipe León Madero
Luis Felipe León Madero
LLLarissa López-Rodriguez
Larissa López-Rodriguez
MAMónica Aguinaga-Ríos
Mónica Aguinaga-Ríos
SVSamuel Vargas-Trujillo
Samuel Vargas-Trujillo
AFAngelica Castañeda de la Fuente
Angelica Castañeda de la Fuente
RMRosalba Sevilla Montoya
Rosalba Sevilla Montoya
Background: Recurrent pregnancy loss (RPL) is a multifactorial condition in which genetic variants associated with thrombophilia may contribute to altered coagulation and adverse pregnancy outcomes. Objective: This study aimed to investigate the association between thrombophilia-related single nucleotide variants (SNVs) and coagulation-related metabolites in a cohort of Mexican women with RPL. Methods: A retrospective and descriptive design was conducted including 105 women with at least two consecutive miscarriages and with a multidisciplinary approach that included a thrombophilia-associated SNVs panel. Peripheral blood samples were collected after fasting for biochemical and molecular analyses. Genotyping of thrombophilia-associated SNVs was performed using real-time PCR with custom-designed TaqMan probes on a Rotor-Gene Q platform, including variants in AGT (rs4762, rs699), F7 (rs6046), FGB (rs1800790), MTR (rs1805087), MTRR (rs1801394), MTHFR (rs1801133, rs1801131), F2 (rs1799963), F5 (rs6025), SERPINE1 (rs1799889), F12 (rs1801020), and F13A1 (rs5985) genes. Coagulation parameters evaluated were folic acid, cobalamin, fibrinogen, D-dimer, homocysteine, antithrombin III activity, thrombin time (TT), prothrombin time (PT), activated partial thromboplastin time (aPTT), international normalized ratio (INR), and Factor XII activity. Results: Significant differences were found in INR values across F7-rs6046 genotypes (p = 0.006), with an additive model showing a mean difference of 0.05 (p = 0.0009). The F12-rs1801020 variant was strongly associated with Factor XII activity (p = 0.002) and aPTT (p = 0.045). Conclusions: These findings indicate that F7-rs6046 and F12-rs1801020 genotypes influence specific coagulation parameters, suggesting that certain thrombophilia-associated SNVs may modulate the hemostatic profile in Mexican women with RPL and contribute to personalized risk assessment in reproductive medicine.

3 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
LMLuis Felipe León Madero
Luis Felipe León Madero
LLLarissa López-Rodriguez
Larissa López-Rodriguez
MAMónica Aguinaga-Ríos
Mónica Aguinaga-Ríos
SVSamuel Vargas-Trujillo
Samuel Vargas-Trujillo
AFAngelica Castañeda de la Fuente
Angelica Castañeda de la Fuente
RMRosalba Sevilla Montoya
Rosalba Sevilla Montoya
Background: Recurrent pregnancy loss (RPL) is a multifactorial condition in which genetic variants associated with thrombophilia may contribute to altered coagulation and adverse pregnancy outcomes. Objective: This study aimed to investigate the association between thrombophilia-related single nucleotide variants (SNVs) and coagulation-related metabolites in a cohort of Mexican women with RPL. Methods: A retrospective and descriptive design was conducted including 105 women with at least two consecutive miscarriages. Peripheral blood samples were collected after fasting for biochemical and molecular analyses. Genotyping of thrombophilia-associated SNVs was performed using real-time PCR with custom-designed TaqMan probes on a Rotor-Gene Q platform, including variants in AGT (rs4762, rs699), F7 (rs6046), FGB (rs1800790), MTR (rs1805087), MTRR (rs1801394), MTHFR (rs1801133, rs1801131), F2 (rs1799963), F5 (rs6025), SERPINE1 (rs1799889), F12 (rs1801020), and F13A1 (rs5985) genes. Coagulation parameters evaluated were folic acid, cobalamin, fibrinogen, D-dimer, homocysteine, antithrombin III activity, thrombin time (TT), prothrombin time (PT), activated partial thromboplastin time (aPTT), international normalized ratio (INR), and Factor XII activity. Results: Significant differences were found in INR values across F7-rs6046 genotypes (p = 0.006), with an additive model showing a mean difference of 0.05 (p = 0.0009). The F12-rs1801020 variant was strongly associated with Factor XII activity (p = 0.002) and aPTT (p = 0.045). Conclusions: These findings indicate that F7-rs6046 and F12-rs1801020 genotypes influence specific coagulation parameters, suggesting that certain thrombophilia-associated SNVs may modulate the hemostatic profile in Mexican women with RPL and contribute to personalized risk assessment in reproductive medicine.

2 January 2026
Verified
Book Chapter
Closed access
PDF file
LMLuis Felipe León Madero
Luis Felipe León Madero
LFLuis Felipe
Luis Felipe
ADAmichia Dioulo
Amichia Dioulo
JBJean Antoine Marie Becelli
Jean Antoine Marie Becelli
MAMartínez Arano
Martínez Arano
AFAngelica Castañeda de la Fuente
Angelica Castañeda de la Fuente

26 June 2026 in Prenatal Diagnosis
Verified
Journal Article
Open access
LLLópez‐Rodríguez Larissa
López‐Rodríguez Larissa
LMLuis Felipe León Madero
Luis Felipe León Madero
JSJiménez‐Chaidez Salvador
Jiménez‐Chaidez Salvador
GMGallardo‐Gaona Juan Manuel
Gallardo‐Gaona Juan Manuel
RJRodríguez‐Sibaja María Jose
Rodríguez‐Sibaja María Jose
RMRosalba Sevilla Montoya
Rosalba Sevilla Montoya
Objective: To review the published literature on prenatal findings of COL2A1 ‐related SEDC, summarizing reported imaging and molecular variants, and to describe two additional prenatal cases evaluated at a tertiary referral center. Method: A narrative review with a systematic search strategy was conducted to analyze prenatal imaging findings, gestational age at detection, and molecular diagnoses in cases of COL2A1 ‐related SEDC. Clinical and molecular description of two additional fetal cases with postnatal molecular confirmation were also included. Results: Gestational age at initial detection ranged from 11 to 28 weeks. Five reported cases occurred in a familial setting, while two were initially considered sporadic. In several cases, complementary imaging modalities were required to better characterize vertebral and ossification defects. A clear genotype–phenotype correlation could not be reliably established; no specific molecular pattern reliably predicted the severity of prenatal imaging findings or perinatal outcomes. Conclusion: Our findings highlight the nonspecific nature of prenatal manifestations in COL2A1‐related SEDC, which despite being largely consistent across cases do not allow for a specific diagnosis without molecular confirmation or a known family history. These challenges underscore the need for a comprehensive diagnostic strategy that integrates detailed imaging, molecular genetic testing, and close collaboration within a multidisciplinary team.

27 October 2026 in Journal of Community Genetics
Verified
Journal Article
Closed access
PDF file
LMLuis Felipe León Madero
Luis Felipe León Madero
LFLuis Felipe
Luis Felipe
AFAngelica Castañeda-De la Fuente
Angelica Castañeda-De la Fuente
TLTéllez- López
Téllez- López
EMElsy María
Elsy María
AYAin Yan
Ain Yan